SI1196129T1 - Farmacevtski in kozmeticni sestavki, ki obsegajo derivate urokaninske kisline kot odstranjevalce radikalov ali antioksidante - Google Patents

Farmacevtski in kozmeticni sestavki, ki obsegajo derivate urokaninske kisline kot odstranjevalce radikalov ali antioksidante

Info

Publication number
SI1196129T1
SI1196129T1 SI200030789T SI200030789T SI1196129T1 SI 1196129 T1 SI1196129 T1 SI 1196129T1 SI 200030789 T SI200030789 T SI 200030789T SI 200030789 T SI200030789 T SI 200030789T SI 1196129 T1 SI1196129 T1 SI 1196129T1
Authority
SI
Slovenia
Prior art keywords
antioxidants
radical scavengers
pharmaceutical
urocanic acid
acid derivatives
Prior art date
Application number
SI200030789T
Other languages
English (en)
Inventor
Arthur Kammeijer
Joannes Dositheus Bos
Original Assignee
Az Univ Amsterdam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Az Univ Amsterdam filed Critical Az Univ Amsterdam
Publication of SI1196129T1 publication Critical patent/SI1196129T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI200030789T 1999-06-25 2000-06-23 Farmacevtski in kozmeticni sestavki, ki obsegajo derivate urokaninske kisline kot odstranjevalce radikalov ali antioksidante SI1196129T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99202066 1999-06-25
PCT/NL2000/000439 WO2001000145A1 (en) 1999-06-25 2000-06-23 Method for scavenging radicals with urocanic acid, derivatives and analogues
EP00942559A EP1196129B1 (en) 1999-06-25 2000-06-23 Pharmaceutical and cosmetic compositions comprising urocanic acid derivatives as radical scavengers or antioxidants

Publications (1)

Publication Number Publication Date
SI1196129T1 true SI1196129T1 (sl) 2006-04-30

Family

ID=8240366

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030789T SI1196129T1 (sl) 1999-06-25 2000-06-23 Farmacevtski in kozmeticni sestavki, ki obsegajo derivate urokaninske kisline kot odstranjevalce radikalov ali antioksidante

Country Status (12)

Country Link
US (2) US7056938B1 (sl)
EP (1) EP1196129B1 (sl)
JP (1) JP2003506566A (sl)
AT (1) ATE311845T1 (sl)
AU (1) AU5716300A (sl)
CA (1) CA2376870C (sl)
CY (1) CY1104980T1 (sl)
DE (1) DE60024628T2 (sl)
DK (1) DK1196129T3 (sl)
ES (1) ES2253235T3 (sl)
SI (1) SI1196129T1 (sl)
WO (1) WO2001000145A1 (sl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005251906B2 (en) 2004-06-08 2011-03-31 Nsab, Filial Af Neurosearch Sweden Ab, Sverige New disubstituted phenylpiperidines/piperazines as modulators of dopamine neurotransmission
US7993630B2 (en) * 2007-02-17 2011-08-09 Bioderm Research Protection of skin from UV and peroxide
CA2690485A1 (en) * 2007-06-11 2008-12-18 Valletta Health Ip Ee B.V. Urocanic acid derivatives useful for the treatment of immune-related and inflammatory diseases
US7888127B2 (en) 2008-01-15 2011-02-15 Sequenom, Inc. Methods for reducing adduct formation for mass spectrometry analysis
NO333013B1 (no) * 2009-07-06 2013-02-18 Smartfish As Sammensetning omfattende bioaktive aminosyrer eller derivater derav og marin olje i en stabil olje-i-vannemulsjon, og fremgangsmate for fremstilling av nevnte sammensetning.
TW201124138A (en) * 2009-09-02 2011-07-16 Valletta Health B V Imidazole-4-carboxylic acid for use in treating a disease related to extracellular reactive oxygen species
JP5756615B2 (ja) * 2010-11-02 2015-07-29 花王株式会社 オートインデューサー−２阻害剤、並びに歯周病又は齲蝕病の予防及び／又は治療剤
US20140127326A1 (en) * 2011-03-04 2014-05-08 Anil K. Sood Detection of Cancer by Volatile Organic Compounds From Breath
US9305756B2 (en) 2013-03-13 2016-04-05 Agena Bioscience, Inc. Preparation enhancements and methods of use for MALDI mass spectrometry

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3515789A (en) * 1967-07-17 1970-06-02 Hope City Analgesic-hypnotic therapy with 4-imidazoleacetic acid
JPS5749550B2 (sl) * 1972-12-25 1982-10-22
JPH0624978A (ja) * 1992-07-07 1994-02-01 Kuraray Co Ltd 抗アレルギー剤
DE4230076C2 (de) * 1992-09-09 1995-12-14 Beiersdorf Ag cis-Urocaninsäure als Antioxidans
WO1994015946A1 (en) 1993-01-08 1994-07-21 Hybridon, Inc. Synthesis of dimmer blocks and their use in assembling oligonucleotides
DE4405585C2 (de) * 1993-03-03 1997-12-11 Beiersdorf Ag Verwendung von trans-Urocaninsäure zur Behandlung oder Prophylaxe der durch oxidative Beanspuchung hervorgerufenen Hautalterung
DE4307983A1 (de) * 1993-03-13 1994-09-15 Beiersdorf Ag Wirkstoffe und kosmetische und dermatologische Zubereitungen
GB9306473D0 (en) 1993-03-29 1993-05-19 Bioglan Lab Ltd Pharmaceutically useful compounds
US6133318A (en) * 1995-11-15 2000-10-17 Hart; Francis J. Oxalic acid or oxalate compositions and methods for bacterial, viral, and other diseases or conditions
US6281244B1 (en) * 1997-06-05 2001-08-28 Novartis Nutrition Ag Therapeutic use for glycine

Also Published As

Publication number Publication date
DE60024628D1 (de) 2006-01-12
DE60024628T2 (de) 2006-09-21
ATE311845T1 (de) 2005-12-15
CA2376870A1 (en) 2001-01-04
JP2003506566A (ja) 2003-02-18
WO2001000145A1 (en) 2001-01-04
DK1196129T3 (da) 2006-04-03
EP1196129A1 (en) 2002-04-17
AU5716300A (en) 2001-01-31
US8026268B2 (en) 2011-09-27
CA2376870C (en) 2009-11-24
ES2253235T3 (es) 2006-06-01
US20060106108A1 (en) 2006-05-18
CY1104980T1 (el) 2009-11-04
US7056938B1 (en) 2006-06-06
EP1196129B1 (en) 2005-12-07

Similar Documents

Publication Publication Date Title
MX9604378A (es) Amidas de acido quinolin-2-carboxilico sustituidas, su preparacion y su empleo como medicamentos, asi como productos intermedios.
YU57600A (sh) Derivarti biciklične hidroksaminske kiseline
HK1057752A1 (en) N-phenyl-2-pyrimidine-amine derivatives
MY139303A (en) Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
TW352384B (en) Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals
MX9503529A (es) Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen.
IL150257A0 (en) Galactomaninan oligosaccharides, pharmaceutical compositions containing the same and methods for the production thereof
MY122391A (en) Piperazine derivatives as 5-ht1b antagonists
MY115211A (en) Novel amino acid derivatives, their preparation and use
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
UA49884C2 (uk) ПОХІДНІ <font face="Symbol">a</font>-ГІДРОКСИКАРБОНОВОЇ КИСЛОТИ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
AU1727797A (en) Heterocyclic biaryl compounds, pharmaceutical and cosmetic compositions containing them and uses thereof
IL131407A0 (en) Tetrahydropyrido compounds medicaments containing the same and the use thereof
SI1196129T1 (sl) Farmacevtski in kozmeticni sestavki, ki obsegajo derivate urokaninske kisline kot odstranjevalce radikalov ali antioksidante
MY120683A (en) New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals.
IL141325A0 (en) Tan-1057 derivatives
HK1056725A1 (en) 2-Thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry.
MXPA04005552A (es) Analogos de vitamina d.
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
MXPA03001455A (es) Compuestos de pirazol, composiciones farmaceuticas y metodos para modular o inhibir la actividad del amiloide-beta-peptido asociado a reticulo endoplasmico y l-3-hidroxiacil-coa-deshidrogenasa.
MXPA04001328A (es) Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso.
WO2004046096A3 (en) Novel ligands that are antagonists of raf receptors, process for preparing them and use thereof in human medicine and in cosmetics
TW200504051A (en) Novel acridine derivatives and their use as medicaments
HK1042300A1 (en) Polycyclic thiazole systems and their utilization as anorectics.
WO2005056510A3 (en) Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics